IN THIS ISSUE
Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease
Pharmacogenetic research and data protection - challenges and solutions
Overview of the pharmacogenetics of HIV therapy
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use
A marker for Stevens-Johnson syndrome ...: ethnicity matters
Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins
Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS